Conceptus, Inc. (CPTS)
-NasdaqGS 30.92 
0.02(0.06%) May 17, 4:00PM EDT|After Hours
:
30.92 0.00 (0.00%) May 17, 4:32PM EDT
| Prev Close: | 30.94 |
|---|
| Open: | 30.95 |
|---|
| Bid: | 26.00 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 28.00 |
|---|
| Beta: | 0.79 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 30.92 - 30.98 |
|---|
| 52wk Range: | 15.81 - 31.10 |
|---|
| Volume: | 1,968,664 |
|---|
| Avg Vol (3m): | 721,459 |
|---|
| Market Cap: | 1.02B |
|---|
| P/E (ttm): | 105.89 |
|---|
| EPS (ttm): | 0.29 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CE Mark for STJ's ILUMIEN OPTISZacks(Fri, May 17)
- CONCEPTUS INC FinancialsEDGAR Online Financials(Fri, May 17)
- Stryker Reiterated at NeutralZacks(Fri, May 17)
- Alleged Patent Infringement by BSXZacks(Fri, May 17)
- Medical Device Companies Trading at 7% Free Cash Flow Yield: Portfolio Manager Mark W. Oelschlager Discusses Investing in Overlooked AreasWall Street Transcript(Fri, May 17)
- Covidien Prices Senior NotesZacks(Thu, May 16)
- Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co.Zacks(Thu, May 16)
- Study for STJ's Latest EnligHTNZacks(Wed, May 15)
- Primecap Rides Health to Top Growth Fund: Riskless Returnat Bloomberg(Wed, May 15)
- Good News for STJ's DurataZacks(Tue, May 14)
- Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Conceptus, Inc. (CPTS)Business Wire(Mon, May 13)
- Genomic Gains Coverage for DCISZacks(Mon, May 13)
- CE Mark for STJ's Ellipse & AssuraZacks(Mon, May 13)
- Earnings Beat for PETS, Margins UpZacks(Mon, May 13)
- Stryker Hits New 52-Week HighZacks(Fri, May 10)
Key Statistics
| Forward P/E (1 yr): | 77.30 |
|---|
| P/S (ttm): | 7.04 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.27 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.06 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 5.73 |
|---|
Business Summary
Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and Europe.
View More